Eric Lefkofsky is a man on a mission. He wants to innovate solutions to one of the biggest medical challenge of modern times; Cancer. This disease has been the source of pain for many families across the globe. Through Tempus, a startup that specializes in fighting cancer, Eric Lefkofsky will provide crucial data of breast cancer patients to the medical fraternity at the University of Chicago.
Tempus’ partnership with the University of Chicago is expected to stir a shift in the way in which medical professionals deal with cancer. Tempus wants to be the source of personalized therapies for people living with cancer through research on patients’ molecular and genomic sequences. The first project for Tempus is to collect data from 1,000 people living with breast cancer and avail it to the doctors at the University of Chicago for further research. The doctors will then seek useful patterns that could guide the administration of future therapies.
According to Dr. OlufunmilayoOlopade, a medical expert in medicine and human genetics, the challenge in treating cancer is that, against a huge number of cancer patients who have battled the disease, there exists little data of those patients’ genetic makeup and how they responded to various therapies. The lack of enough data forces doctors to administer medicines without knowing what might be the outcome of those treatments.
Through the power of machine learning and sequencing each patient’s genome, the research will guide future therapies and might enable the creation of more personalized treatments. Tempus was created in the year 2015 and only became known to the public in 2016 and learn more about Eric.
Eric Lefkofsky has recorded a lot of success in the business world. He is revered for having created some of the most successful technology startups. Groupon is one of these startups that has exceeded the expectations of many regarding growth. Eric boasts of a J.D. at laws from the University from the prestigious University of Michigan and more information click here.
The partnership of Tempus with the University of Chicago is part of the several strategic alliances that Tempus has built to innovate the best ways of treating diseases such as cancer and his twitter.